Mixed — no quarterly financials disclosed; presentation is a long-term strategic overview with ambitious capacity expansion plans and a $1B revenue target, but lacks any near-term performance data. quarter Investor Presentation One-Pager? Mar 2026

Revenue (FY2025)

₹816 Cr

FY2025 full year; no quarterly figure provided in presentation.

EBITDA Margin (FY2025)

17%

Up from 12% in FY1995 and 15% in FY2005; trend positive.

Planned Capex (3-5 years)

₹300 Cr

₹50 Cr for SS sinks, ₹30 Cr for granite sinks, ₹30 Cr for appliances, ₹10 Cr for faucets & food waste.

What Went Right

Carysil is Asia's #1 granite sink manufacturer with German technology, exporting to 55+ countries across 35+ years.
Revenue grew from ₹12 Cr (FY1995) to ₹816 Cr (FY2025), a 68x increase; EBITDA margin improved from 12% to 17%.
Management outlined a phased capex of ₹300 Cr to expand capacities: SS sinks by 50% to 1.5M units, granite sinks by 178% to 0.5M units, appliances by 300% to 0.2M units.
Product innovation pipeline includes MAGNA 90 chimney, PLASMAHOOD filterless, KOLN induction hob, RO faucets, and new granite sink series.

What to Watch

No quarterly financial data (revenue, margin, PAT) was provided; the presentation is a strategic forward-looking document without any Q4 FY2026 results.
The $1B revenue target (₹8,400 Cr at current rates) is set 12-15 years out, implying a ~13% CAGR — achievable but requires flawless execution and favourable macro.
Segment-wise revenue breakdown is absent; it is unclear how much stainless steel sinks vs. kitchen appliances vs. faucets contribute to overall sales.
The presentation omits any discussion of debt levels, working capital, or cash flow, making it hard to assess financial health of the ₹300 Cr capex plan.

Management Guidance

Revenue target of $250M (approx. ₹2,100 Cr) in the next 3-5 years.
Revenue target of $500M (approx. ₹4,200 Cr) in the next 8-10 years.
Revenue target of $1B (approx. ₹8,400 Cr) in the next 12-15 years.
Capacity expansion: SS sinks from 1,000,000 to 1,500,000 by FY30/FY31; granite sinks from 180,000 to 500,000 by FY30/FY31; appliances from 50,000 to 200,000 by FY30/FY31; faucets & food waste from 50,000 to 200,000 by FY30/FY31.

Investor Lens

The long-term thesis remains intact: Carysil has a strong domestic and export franchise, technology-led manufacturing, and a clear plan to become a one-stop kitchen & bathroom platform. However, near-term weaknesses are glaring — no Q4 FY2026 financials were shared, leaving investors in the dark about current momentum. The ₹300 Cr capex, while ambitious, brings execution risk and could pressure margins until new capacities ramp up. The $1B target, though exciting, is far off and hinges on premiumization, channel expansion, and private-label mix. Next quarter, watch for Q1 FY2027 revenue growth, EBITDA margin trends, and any updates on capex deployment and debt levels to validate the story.

From investor presentation · AI-generated analysis · Not investment advice

🔒

Premium Feature

Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance

Upgrade to Premium

Already a member? Log in

📈 STRONG Net profit up 42% YoY to ₹27 Cr, margins expand

Revenue

Revenue grew 14.7% YoY to ₹234.0 Cr, with sequential growth of 4.9% QoQ, indicating sustained demand momentum.

Profitability

Net Profit surged 42.1% YoY to ₹27.0 Cr, driven by revenue growth and margin expansion. EPS improved from ₹6.54 to ₹9.53. Operating Profit rose 28.6% YoY to ₹45.0 Cr.

Margins

Operating Profit Margin (OPM) improved to 19% from 17% a year ago, supported by better cost management and operating leverage. QoQ margin held steady at 19%.

Cash Flow

No data provided.

Balance Sheet

Borrowings stood at ₹274 Cr against reserves of ₹603 Cr, resulting in a Debt/Equity ratio of 0.42. Total assets were ₹1,042 Cr.

Key Risks

High PE of 28.9 suggests premium valuation that may compress if growth slows. Debt of ₹274 Cr could strain cash flows if interest rates rise. Reliance on consumer discretionary spending makes revenue sensitive to economic cycles.

Outlook

With consistent revenue growth and margin improvement, the company appears positioned for further gains if demand sustains. However, high valuation and debt levels warrant monitoring for any deviation from the current growth trajectory.

Generated by AI · Mar 2026 results · Not investment advice

🔒

Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free Account Log In

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock AI Advisor.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to Premium Create Free Account

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to Premium Create Free Account

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Documents.

Access concall transcripts, annual reports, credit ratings, and investor presentations.

Upgrade to Premium Create Free Account

💼 Management Guidance

Revenue, loan book, NIM and other management targets — with hit/miss tracking

🔒

Premium Feature

Management guidance targets with historical hit/miss tracking — unlocked with Premium

Upgrade to Premium

Already a member? Log in

🎯 Thesis Tracker

Guidance vs Delivery — management track record

🔒

Premium Feature

Management guidance vs actual delivery — track whether revenue & PAT targets were Beat, Met or Missed across every reporting year

Upgrade to Premium

Already a member? Log in

🔒

Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to Premium Create Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including equities and mutual funds, involves inherent risks, including the potential loss of principal. All investments are subject to market fluctuations, regulatory changes, and other risks that may affect their value. Past performance is not indicative of future results. This report is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This report does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a SEBI-registered investment adviser or other qualified financial professional before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities or financial instruments discussed in this report. Any such positions, if material, are disclosed to the best of the author's knowledge and are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company, institution, or third party.

Information Sources:
The analysis and opinions expressed herein are based on publicly available information, including but not limited to company filings with the BSE/NSE, annual reports, management commentary, investor presentations, data from the Reserve Bank of India (RBI), SEBI, industry publications, and other reliable financial data sources. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This report may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. The author does not undertake any obligation to update such statements in the future.

Regulatory Compliance:
This report is intended to comply with the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, as amended, and other applicable Indian laws and regulations.

Limitation of Liability:
The content of this report is provided "as is" without any warranties, express or implied, including accuracy, completeness, merchantability, or fitness for a particular purpose. The author and publisher expressly disclaim any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.